[go: up one dir, main page]

GB0407620D0 - Cell lines - Google Patents

Cell lines

Info

Publication number
GB0407620D0
GB0407620D0 GB0407620A GB0407620A GB0407620D0 GB 0407620 D0 GB0407620 D0 GB 0407620D0 GB 0407620 A GB0407620 A GB 0407620A GB 0407620 A GB0407620 A GB 0407620A GB 0407620 D0 GB0407620 D0 GB 0407620D0
Authority
GB
United Kingdom
Prior art keywords
cell lines
lines
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB0407620A
Other versions
GB2400103A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ionix Pharmaceuticals Ltd
Original Assignee
Ionix Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0307633A external-priority patent/GB0307633D0/en
Priority claimed from GB0307632A external-priority patent/GB0307632D0/en
Application filed by Ionix Pharmaceuticals Ltd filed Critical Ionix Pharmaceuticals Ltd
Publication of GB0407620D0 publication Critical patent/GB0407620D0/en
Publication of GB2400103A publication Critical patent/GB2400103A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5058—Neurological cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GB0407620A 2003-04-02 2004-04-02 Cell lines expressing VGSC, Nav1.8 Withdrawn GB2400103A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0307633A GB0307633D0 (en) 2003-04-02 2003-04-02 Chemical compounds
GB0307632A GB0307632D0 (en) 2003-04-02 2003-04-02 Chemical compounds
US47557003P 2003-06-04 2003-06-04
US48573003P 2003-07-10 2003-07-10
US48573503P 2003-07-10 2003-07-10

Publications (2)

Publication Number Publication Date
GB0407620D0 true GB0407620D0 (en) 2004-05-05
GB2400103A GB2400103A (en) 2004-10-06

Family

ID=32303749

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0407620A Withdrawn GB2400103A (en) 2003-04-02 2004-04-02 Cell lines expressing VGSC, Nav1.8

Country Status (2)

Country Link
GB (1) GB2400103A (en)
WO (1) WO2004087956A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070083828A (en) * 2004-10-27 2007-08-24 쉐링 코포레이션 Compositions and Methods for Inhibition of Short Interfering Nucleic Acids
WO2007056326A2 (en) * 2005-11-04 2007-05-18 Alnylam Pharmaceuticals, Inc. Compositions and methods for inhibiting expression of nav1.8 gene
FR3007656B1 (en) * 2013-06-28 2015-06-26 Galderma Res & Dev MODULATORS OF THE NAV1.9 SODIUM CHANNEL FOR THE TREATMENT OF INFLAMMATORY SKIN DISEASE AND DIAGNOSTIC METHODS
FR3007763A1 (en) * 2013-06-28 2015-01-02 Galderma Res & Dev ANTIBODIES AGAINST THE HUMAN NAV1.9 SODIUM CHANNEL AND THEIR USES IN DIAGNOSIS
FR3007762B1 (en) * 2013-06-28 2015-09-04 Galderma Res & Dev ANTIBODIES AGAINST THE HUMAN NAV1.9 SODIUM CHANNEL AND THEIR USES FOR THE DIAGNOSIS OF INFLAMMATORY SKIN DISEASES

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9513180D0 (en) * 1995-06-28 1995-08-30 Univ London Ion channel
US6184349B1 (en) * 1995-10-11 2001-02-06 Syntex (Usa) Inc. Cloned peripheral nerve, tetrodotoxin-resistant sodium channel α-subunit
GB9929970D0 (en) * 1999-12-17 2000-02-09 Glaxo Group Ltd Sodium channel proteins
GB0006024D0 (en) * 2000-03-14 2000-05-03 Glaxo Group Ltd Altered ion channel proteins
DE10054878A1 (en) * 2000-11-06 2002-05-08 Boehringer Ingelheim Int Peripheral nerve type sodium channels
AU2002354569A1 (en) * 2001-07-12 2003-01-29 Merck And Co., Inc. Electrical field stimulation of eukaryotic cells
JPWO2003016907A1 (en) * 2001-08-17 2004-12-02 エーザイ株式会社 Reagent and method for measuring laminin 5 antigen in biological sample
GB0120238D0 (en) * 2001-08-20 2001-10-10 Univ College Of London Sodium channel regulators and modulators
ATE541847T1 (en) * 2001-11-01 2012-02-15 Icagen Inc PYRAZOLOPYRIMIDINES AS SODIUM CHANNEL BLOCKERS

Also Published As

Publication number Publication date
WO2004087956A2 (en) 2004-10-14
WO2004087956A3 (en) 2005-03-03
GB2400103A (en) 2004-10-06

Similar Documents

Publication Publication Date Title
AU2003265826A8 (en) Electrolyte
EP1615948A4 (en) Immuno-amplification
EP1635758A4 (en) Orthodynamic rehabilitator
DE502004009243D1 (en) Spirocyclische cyclohexan-derivate
GB0323436D0 (en) Battery arrangement
HK1096487A1 (en) Photovoltaic cell
GB0206357D0 (en) Cells
AU157289S (en) Battery
DE602004012262D1 (en) Benzimidazolonverbindung
GB2421742B (en) Structural arrangement
GB0308128D0 (en) Concentrator
TW559446U (en) Case structure
GB0407620D0 (en) Cell lines
GB2384718B (en) Carry curbz
GB0328943D0 (en) Differentiated cells
IL158173A0 (en) Nanopatch-containing cells
AU155419S (en) Trivette
GB0226482D0 (en) Elecrochemical cell
GB0301834D0 (en) Methods employing cells
HU0300511D0 (en) Carbohydrid battery
GB0323824D0 (en) Structure
TW571835U (en) Sprayer-nozzle structure
IL150303A0 (en) Cell interface
TW566242U (en) Structure for dual-hole type sprayer-nozzle
GB0421753D0 (en) Cell line

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)